Search

everythinglearnresearchcommunity

for

Search:↓

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Two mouse mutations cause similar hair loss despite different skin changes.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Common skin conditions can greatly affect a person's mental health and social life.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Genetic factors and diet significantly increase the risk of male pattern baldness.

Minoxidil and finasteride effectively treat hair loss.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Reflectance confocal microscopy is useful for diagnosing and monitoring skin diseases, but it has limitations and requires expertise for correct use.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.